The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
Sleep Europe 2024 | The latest developments in the treatment of RLS
Celia Garcia-Malo, MD, PhD, Centro Integral de Sueño y Neurociencias CISNe, Madrid, Spain, discusses recent advancements in the treatment of restless legs syndrome (RLS) and highlights some novel agents being investigated. As the knowledge of the pathophysiology of RLS has improved, the central role of iron in its pathophysiology has been elucidated. Therefore, iron supplementation is now recommended as a first-line treatment for patients. Dopaminergic agents are avoided due to the risk of augmentation phenomena. This interview took place at the Sleep Europe 2024 congress in Seville, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
